Sutro Biopharma, Inc.

• Sutro Biopharma, Inc. Estimates – NASDAQ:STRO
  TradingView · 23 Oct 2026
• Sutro Biopharma doses first patient in STRO-006 trial
  TipRanks · 21 Oct 2026
• Sutro Biopharma doses first patient in STRO-006 phase 1 trial
  Investing.com Australia · 21 Oct 2026
• Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
  The Manila Times · 21 Oct 2026
• Sutro's second antibody-linked cancer drug entered human testing in less than a year.
  Stock Titan · 21 Oct 2026
• H.C. Wainwright reiterates Sutro Biopharma stock rating at buy
  Investing.com · 16 Oct 2026
• Sutro Biopharma (STRO) Pulls Back 6.85% to $14.27 as Shares Test Key Support Zone - Gap Fill Strategy
  https://www.dars.gov.et/ · 11 Oct 2026
• Sutro Biopharma (STRO) Pulls Back 6.85% to $14.27 as Shares Test Key Support Zone - Volume Nodes
  https://www.siam.in/ · 11 Oct 2026
• Form 4 Sutro Biopharma For: 27 September By Investing.com
  Investing.com India · 27 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →